Friday 29 November 2013

Medicinal Chemistry:

A rapidly growing discipline of Medicinal Chemistry explains the relation of structure and function for a better understanding of the molecular basis of life. Application of chemical research techniques with the fusion of pharmaceuticals come under the Medicinal Chemistry field.
During the early phase of Medicinal Chemistry development, the only concern for scientists was to isolate medicinal agents found in plants. Today, creation of new synthetic drug compounds is a topic equally concerning the scientists in medical chemistry field. They are almost ready to move forward in the drug discovery and development.

Drug development is an expensive and time-consuming process. The complexity of the process is shown by the fact that, its cost has now reached to $800 million in order to convert a promising new compound into a drug on the market. Moreover, it takes around 15 years on an estimate. This reflects the need for pharmaceutical and biopharmaceutical firms to reduce the cost and drug development period.
Bentham Science Publishers is an established name in the STM industry. They have a lot of e-books and journals based on medicine. Medicinal Chemistry is one of their journals with an impact factor of 4.07.The journal is recommended for every medicinal chemist who aims to contribute in the growth of scientific knowledge and insight, and facilitate the discovery and development of new therapeutic agents to treat debilitating human disorders.

To read more on the medicinal chemistry drug development please visit: http://www.benthamscience.com/cmc/

Thursday 28 November 2013

A Hope For HIV/AIDS Infected Infants:

AIDS is the final stage of HIV, or human immunodeficiency virus. HIV virus attacks the immune system in a way that it destroys the healthy white blood cells (CD4+) T cells, which are crucial for fighting off infections in the body. When these healthy cells are destroyed, patients of HIV get prone to other serious diseases and infections.

ART, antiretroviral therapy is the treatment used for this disease.  It is a combination of HIV medicines regimen. Although, ART can’t cure the disease completely, it does help the patients in living a healthier and longer life.
Over the past several years, the researchers have learnt a lot about HIV/AIDS. Despite of rigorous research being done on HIV/AIDS millions of people whose health continues to be threatened by the universal HIV/AIDS pandemic. World AIDS’ day is celebrated on the 1st of December every year for educating the common people and helping the effects.
There are 3.4 million children affected with HIV worldwide, according to WHO, while 91% of them are in the Saharan-Africa region.  Majority of these children get affected of HIV get infected from their HIV-infected mothers during pregnancy, emphasizing the need of infant HIV treatment.
Recently, good news has surfaced that an infant, a 3 year old girl from Mississippi, who was born with HIV has been almost cured, and is in remission for 18 months. If antiretroviral treatment started within the first hours or days of infection, remission can be achieved.
To read further about HIV/AIDS, you can visit Bentham Science Publishers journals online. It is a reputable scientific and medical journal publication, having a number of credible journals and eBooks on revolving around; natural science, medicine, information technology etc. For instance, “Soluble Factors Mediating Innate Immune Responses to HIV Infection” is a published eBook, focused on interaction between innate immunity and HIV infection.

Thursday 21 November 2013

Bentham Science eBooks: Evidence-Based Occlusal Management for Temporomandibular Disorders:

Bentham eBooks is a comprehensive online book’s publication program anticipated to cover all major disciplines like health and natural sciences, technology, humanities and social sciences. Bentham e-book offers authors flexible publication solutions. These electronic books are rapidly published using state-of-the-art internet technology with the maintenance of the highest publication standards.

Here is the review of one of the recent e-books of Bentham, “Evidence-Based Occlusal Management for Temporomandibular Disorders.” This e-book describes that current mainstream treatments for temporomandibular disorders (TMDs) are mainly conservative therapies. However, these conservative treatments are symptomatic treatments, not causal treatments. Therefore, the patients with severe symptoms have not been completely relieved.
The e-lecture also demonstrates a positive outcome using causal treatment based on occlusal equilibration in the BPOP based on the evidence of a relationship between occlusal discrepancy and TMD. Therefore, this e-book shares insightful, evidence-based clinical data with interested readers such as dental clinicians and researchers around the world.
To read more about this e-book visit:
For further details about the latest e-books visit:

Tuesday 12 November 2013

Bentham Science e-Books: Lung Cancer: Clinical and Surgical Specifications:

Here is the review of one of the recent e-Books of Bentham; “Lung Cancer: Clinical and Surgical Specifications.” This book answers the needs of medical professionals seeking this information and includes both internal and surgical aspects of lung cancer as well as developments in molecular research on pulmonary oncology.
Lung Cancer diagnosis worldwide has advanced considerably. Progress in diagnostic techniques and therapeutic methods has greatly improved life expectancy in lung cancer patients. Information on lung cancer diagnosis and treatment is therefore useful for all medical professionals especially those who work outside the realm of pulmonology or onclology.
 The e-book is divided into several sections which cover basic research on lung cancer epidemiology and carcinogenesis and continue through treatment modalities on non-resectable and advanced stage lung cancer cases (radiofrequency ablation, microwave ablation) and new diagnostic techniques (PET scan). The e-book also contains a section dedicated to surgical treatment options in lung cancer patients. Readers will be able to equip themselves with the necessary medical information for diagnosing lung cancer and treating patients requiring surgery.
To read more about this Bentham e-Book visit:

Monday 4 November 2013

Bentham eBook: Toxic Effects of Nanomaterials

Bentham Science Publishers offer various e-books in all areas of technology, natural science, humanities and medicine. eBooks at Bentham science are published by means of state-of-the-art internet technology.
Here is the recent review of one of the Bentham eBooks: “Toxic Effects of Nanomaterials”
Toxic Effects of Nanomaterials provides an authoritative work of international experts in the field of nanotoxicology spanning 8 chapters. A key feature of the e-book is a broad coverage of the phytotoxicity of nanoparticles, which is largely neglected in many texts. The first couple of chapters of this book deal with the toxicity of nanoparticles in plants. This is followed by a discussion on the toxicities of iron oxide, titanium oxide and silicon oxide nanoparticles. Next, the volume provides a comprehensive review of the methodologies used in nanotoxicology surveys. The concluding chapters highlight the risks associated with the use of nanoparticles and the environmental impact of nanomaterials. Such a broad coverage of nanotoxicology renders this book highly beneficial to the scientists from multidisciplinary areas including nanotechnologists, toxicologists, pharmacologists, environmental chemists and biomedical scientists. This book would equally be useful for the individuals advocating for sustainable use of nanotechnology.

To read more about this eBook, you can visit: http://www.benthamscience.com/ebooks/9781608052837/index.htm

Friday 1 November 2013

Bentham Science eBooks: Frontiers in Clinical Drug Research – Central Nervous System

Here is the review of one of the recent e-books of Bentham; “Frontiers in Clinical Drug Research-Central Nervous System”. This e-book presents the latest research and clinical studies on the central nervous system (CNS).
It covers a range of topics such as the development and pathophysiology of the brain and spinal cord, physiological sites of drug action in the CNS and clinical findings on drugs used to treat CNS defects due to injury or impaired development. In addition to clinical research on humans, the book also highlights other avenues of CNS medicine and research such as pain medicine, stem cell research, pharmacology, toxicology and translational models in animals.
The first volume of the series features chapters on the topics like nerve targets in pain medicine, spinal cord injury, research on neutroxins targeting voltage gated ion channels, G protein coupled receptor agonists and modulators, drug research on mediating hypoxia in developing white matter.
To read more about this Bentham e-Book visit: